This is an aggregated industry headline. Read the full story at PharmaVoice →
HHS, industry leaders spar over drug pricing, TrumpRx and PBMs
Debate about drug costs erupted among prominent healthcare figures, including Dr. Oz, Mark Cuban, Calley Means and PhRMA in Washington, D.C., but they all agreed on one thing: The system is broken.
By PharmaVoice
· Apr 23, 2026
· via PharmaVoice
Image: PharmaVoice
Tags
policyformat:headlineheadlinePharmaVoice
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Policy
All Policy →
PolicySTAT News ↗
Mifepristone, involved in most abortions in the U.S., can now be distributed only in person and at clinics.…
PolicyBriefing
A judge approved Purdue Pharma’s criminal sentence, clearing the way for the company’s dissolution after years…